Cardiovascular Diseases

818 trials 341 recruiting

Filter these 818 trials by phase, country and sponsor.

Open in Search →

A study evaluating the efficacy and safety of ralinepag in treatment of patients with pulmonary arterial hypertension. Ended

2023-509304-16-00 Pulmonary arterial hypertension (PAH) 5 2019-05-16
Danish trial of beta blocker treatment after myocardial infarction without reduced ejection fraction (DANBLOCK) Ended

2024-515748-22-01 Myocardinal infarction 5 2018-12-01
The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial Ended

2024-518736-37-00 Risk of stroke by Atrial Fibrillation 6 2018-01-12
Clinical trial to evaluate the efficacy of intracoronary infusion of autologous bone marrow mononuclear in patients with dilated cardiomyopa… Ended

2024-516594-71-01 Idiopathic dilated cardiomyopathy 4 2013-12-12
Impact of Multiple Doses of BAY63-2521 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Interstitial Lung Dis… Ended

2023-507526-17-00 "Patients with interstitial lung disease associated pul 4 2008-05-13
ARIISE - ASCs in recently diagnosed non-ischemic heart failure Ended

2025-520837-22-00 Non-ischemic heart failure with reduced ejection fracti 4
VEGF-D gene therapy in severe coronary artery disease. Phase II clinical trial (ReGenHeart). Ended

2024-512255-20-00 Clinical development and proof of principle testing of 4
Cluster randomised trial of blood thinners Ended

2022-502402-32-00 Venous thromboembolism 6
Early ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy Ended

2023-508743-43-00 Hypertrophic cardiomyopathy (HCM) is the most common ge 6
Double-blind, Randomized, Placebo-controlled Study Evaluating Efficacy and Safety of IgPro20 in post-COVID-19 POTS Ended

2023-508744-22-00 Post-COVID-19 Postural Orthostatic Tachycardia Syndrome 5
REDUAL PCI Real Life Registry Ended

2024-518666-27-00 Acute coronary syndrome 11
A Clinical Study to Compare the Impact of Multiple-dose Oral Administration of Macitentan, 10 mg versus 75 mg on Endothelin-1 Clearance, End… Ended

2023-504643-13-00 Pulmonary Arterial Hypertension 3
Evaluation of the effect of para-sternal block on respiratory function after cardiac sternotomy surgery. Study prospective, controlled, rand… Ended

2024-513301-30-00 cardiac surgery 6
DANHEART Ended

2024-514212-27-00 Heart failure 5
FIRST-IN-HUMAN OPEN-LABEL MULTICENTRE CLINICAL TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF EPICARDIAL IMPLANTATION OF COLLAGEN MEMBRANES WI… Ended

2024-517738-16-00 ventricular failure caused by ischemic heart disease 1
A trial to learn if itraconazole and carbamazepine affect how AZD5462 moves throughout the bodies of healthy adults Ended

2024-519834-21-00 Chronic Heart Failure 3
A trial to learn if andexanet alfa is safe and works to limit bleeding in people who take factor 10a inhibitors and urgently need surgery Ended

2022-501353-37-00 Reversal of anticoagulation effect in patients on a FXa 5
Testing a New Medication (Etrinabdiona) for Leg Circulation disease: A Study of Safety, Tolerability and Preliminary Efficacy Ended

2023-509452-34-00 Peripheral Arterial Disease 4
Impact of CardiolRxTM on Recurrent Pericarditis: An open label Pilot Study Ended

2023-507452-77-00 Recurrent Pericarditis 3
EDIT-CMD Ended

2024-512030-15-00 Angina 11
CONCISE COlchicine iN Circulating Inflammatory markers after StrokE Ended

2023-506967-33-00 Stroke 4
Inhibition of Mast cell Activation in AtheroScleroTic lesions using an Anti-IgE antibody approach (MAST) Ended

2024-513581-19-00 Carotid artery stenosis 11
A study to learn more about how safe nurandociguat is and how it affects the way the body processes rosuvastatin and dabigatran in healthy a… Ended

2025-524178-40-00 Chronic Kidney Disease 3
Mavacamten Impact on Myocardial Structure in Obstructive Hypertrophic Cardiomyopathy Ended

2022-502316-36-00 Symptomatic Obstructive Hypertrophic Cardiomyopathy 11